The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
COMPARISON OF RIFAMPICIN WITH PHENOBARBITONE FOR TREATMENT OF PRURITUS IN BILIARY CIRRHOSIS
Abstract
The anti-pruritic effects of rifampicin (10 mg/kg) and phenobarbitone (3 mg/kg) were assessed in 22 patients with primary biliary cirrhosis in a crossover randomised clinical trial. Each agent was given for 14 days, with a 30-day washout period between treatments. 21 patients completed the course of rifampicin and 18 that of phenobarbitone; rifampicin was withdrawn from 1 patient when anaemia and renal failure developed, whereas 3 patients stopped taking phenobarbitone because of a rash and the 4th merely refused the drug. Rifampicin had a greater anti-pruritic effect than phenobarbitone. The symptom improved in 19 patients taking rifampicin and in 8 taking phenobarbitone, the degree of improvement being greater with rifampicin than with phenobarbitone. Pruritus disappeared in 9 patients receiving rifampicin, and three of them were free of itch when switching over to phenobarbitone. Both drugs were equally effective in inducing hepatic microsomal function but rifampicin has the additional effect of reducing cholestasis. Its anti-pruritic effect should be tested in long-term clinical trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several prospective randomised placebo-controlled trials have shown rifampicin to be effective in the management of cholestatic pruritus.182–185”
From The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines (2018) · cites this paper as [183]
Citations
Cites
Snedecor, G. W., Cochran, W. G., & STOUT, B. B. (1939) · Soil Science · doi:10.1097/00010694-193902000-00006 · Cited by 19,423
Statistical methods in medical research
Menduke, H. (1972) · Journal of the Franklin Institute · doi:10.1016/0016-0032(72)90050-6 · Cited by 1,271
IS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS?
Poupon, R. Y., Poupon, R., Calmus, Y., Chrétien, Y., Ballet, F., & Darnis, F. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91610-2 · Cited by 534
The presentation and diagnosis of 100 patients with primary biliary cirrhosis
Sherlock, S., & Scheuer, P. J. (1973) · New England Journal of Medicine · doi:10.1056/nejm197309272891306 · Cited by 504
Christensen, E., Crowe, J., Doniach, D., Pópper, H., Ranek, L., Rodés, J., Tygstrup, N., & Williams, R. L. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90571-5 · Cited by 271
Self-citationTreatment of pruritus of primary biliary cirrhosis with rifampin
Podesta, A., Lopez, P., Terg, R., Villamil, F., Flores, D., Mastai, R., Udaondo, C. B., & Companc, J. P. (1991) · Digestive Diseases and Sciences · doi:10.1007/bf01300759 · Cited by 267
Treatment of pruritus in primary biliary cirrhosis with rifampin
Ghent, C. N., & Carruthers, S. G. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90442-8 · Cited by 257
Lindenborn-Fotinos, J., Baum, H., & Berg, P. A. (1985) · Hepatology · doi:10.1002/hep.1840050510 · Cited by 161
Relief of the Pruritus of Jaundice with a Bile-Acid Sequestering Resin
Carey, J. B. (1961) · JAMA · doi:10.1001/jama.1961.03040180034008 · Cited by 134
Phenobarbital Effects in Cholestatic Liver Disease
BLOOMER, J. R., & BOYER, J. L. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-82-3-310 · Cited by 120
Research works printed but not linked: 2
- Pérez-Ayuso, 1980, Effect of phenobarbital treatment on pruritus and hepatic excretory function in primary biliary cirrhosis, Gastroenterology, 79, 1119
- Quintero, 1986, Utilidad del recambio plasmático intermitente en la cirrosis biliar primaria, Gastroenterol Hepatol, 9, 329
Cited by
Sorted by citations
Items 101–200 of 227
Primary biliary cirrhosis: new perspectives in diagnosis and treatment
Prince, M. I., & Jones, D. E. J. (2000) · Postgraduate Medical Journal · doi:10.1136/pmj.76.894.199 · Cited by 37
Management of Chronic Hepatic Itch
Düll, M. M., & Kremer, A. E. (2018) · Dermatologic Clinics · doi:10.1016/j.det.2018.02.008 · Cited by 35
Successful treatment of severe unconjugated hyperbilirubinemia via induction of UGT1A1 by rifampicin
Ellis, E. C. S., Wagner, M., Lammert, F., Németh, A., Gumhold, J., Strassburg, C. P., Kylander, C., Katsika, D., Trauner, M. A., Einarsson, C., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.09.011 · Cited by 35
The Pathological Effects of Circulating Hydrophobic Bile Acids in Alzheimer’s Disease
Ehtezazi, T., Rahman, K., Davies, R., & Leach, A. G. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220071 · Cited by 37
Cholestatic pruritus : an update.
Vloo, C. D., & Nevens, F. (2019) · PubMed · Cited by 34
Flumecinol for the treatment of pruritus associated with primary biliarg cirrhosis
Turner, I. B., Rawlins, M. D., Wood, P., & James, O. (1994) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1994.tb00297.x · Cited by 34
Update on the Treatment of the Pruritus of Cholestasis
Bergasa, N. V. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.11.009 · Cited by 33
Macia, M. L., Avilés, J., Navarro‐González, J. F., Morales, S., & Garcı́a, J. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01354-2 · Cited by 33
Pereira, A., Sanz, C., Cervantes, F., & Castillo, R. (1991) · Annals of Hematology · doi:10.1007/bf01714964 · Cited by 33
Beuers, U. H., Kullak-Ublick, G. A., Pusl, T., Rauws, E. A., & Rust, C. (2008) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-008-8085-y · Cited by 32
Nuclear receptors, bile-acid detoxification, and cholestasis
Chen, J., & Raymond, K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68156-7 · Cited by 32
Medical Treatment of Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis
Holtmeier, J., & Leuschner, U. (2001) · Digestion · doi:10.1159/000048854 · Cited by 33
Use of rifampin in nonstaphylococcal, nonmycobacterial disease
Morris, A. B., Brown, R. B., & Sands, M. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.1.1 · Cited by 32
Smith, H. T., de Souza, A. R., Thompson, A. H., McLaughlin, M., Dever, J. J., Myers, J. A., & Chen, J. V. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-07862-z · Cited by 34
Bolier, R., de Vries, E. S., Parés, A. R., Helder, J., Kemper, E. M., Zwinderman, K. H., Elferink, R. P. J. O., & Beuers, U. H. (2017) · Trials · doi:10.1186/s13063-017-1966-8 · Cited by 32
Self-citationUse of Oral Naltrexone for Severe Pruritus Due to Cholestatic Liver Disease in Children
Zellos, A., Roy, A., & Schwarz, K. B. (2010) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181eb5ac0 · Cited by 30
Stahl, S. H., Davies, M. R., Cook, D. I., & Graham, M. J. (2008) · Xenobiotica · doi:10.1080/00498250802105593 · Cited by 31
Medical Palliation of the Jaundiced Patient with Pruritus
Bergasa, N. V. (2006) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2005.12.008 · Cited by 29
Peripheral Neuronal Mechanism of Itch: Histamine and Itch
Histamine and Itch Robin L. Thurmond, K. K. (2014) · CRC Press eBooks · doi:10.1201/b16573-14 · Cited by 28
Pruritus and cholestasis: Therapeutic options
Gillespie, D. A., & VICKERS, C. R. (1993) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1993.tb01510.x · Cited by 27
Roberts, E. A. (2003) · Wiley eBooks · doi:10.1002/9780470987049.ch4 · Cited by 28
Clinical Hepatotoxicity. Regulation and Treatment with Inducers of Transport and Cofactors
Marschall, H., Wagner, M., Zollner, G., & Trauner, M. (2007) · Molecular Pharmaceutics · doi:10.1021/mp060133c · Cited by 27
Treatment of Primary Biliary Cirrhosis: Therapy with Choleretic and Immunosuppressive Agents
Silveira, M. G., & Lindor, K. D. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.02.008 · Cited by 27
Rifampicin therapy in severe forms of psoriasis
Tsankov, N., & Krasteva, M. (1992) · Journal of Dermatological Treatment · doi:10.3109/09546639209089062 · Cited by 27
Primary Biliary Cirrhosis: New Therapeutic Directions
Berg, C. L., & Gollan, J. L. (1992) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529209095978 · Cited by 27
Treatment of Pruritus Associated with Systemic Disorders in the Elderly
Lonsdale-Eccles, A. A., & Carmichael, A. (2003) · Drugs & Aging · doi:10.2165/00002512-200320030-00004 · Cited by 26
Parés, A. R. (2018) · Medicina Clínica · doi:10.1016/j.medcli.2017.12.021 · Cited by 26
Self-citationSimon, F. R. (1998) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70023-4 · Cited by 24
Treatment of primary biliary cirrhosis
Poupon, R. Y., & Poupon, R. E. (2000) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2000.0107 · Cited by 22
Ataei, S., Kord, L., Harchegani, A. L., Yasrebifar, F., Mehrpooya, M., Seyedtabib, M., & Hasanzarrini, M. (2019) · Reviews on Recent Clinical Trials · doi:10.2174/1574887114666190328130720 · Cited by 21
Bergasa, N. V. (2014) · CRC Press eBooks · doi:10.1201/b16573-10 · Cited by 21
Cholesterol detoxification by the nuclear pregnane X receptor
Kliewer, S. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500159102 · Cited by 21
Extrahepatic Manifestations of Cholestatic Liver Diseases: Pathogenesis and Therapy
Pusl, T., & Beuers, U. H. (2005) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:28:2:147 · Cited by 20
Drug-Induced Liver Injury in the Setting of Chronic Liver Disease
Hoppmann, N. A., Gray, M. E., & McGuire, B. M. (2019) · Clinics in Liver Disease · doi:10.1016/j.cld.2019.09.006 · Cited by 18
Primary biliary cirrhosis: Symptomatic treatment
Elias, E., & Burra, P. (1991) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1991.tb00912.x · Cited by 18
Bergasa, N. V. (1995) · Seminars in Dermatology · doi:10.1016/s1085-5629(05)80052-5 · Cited by 18
Pharmacological interventions for pruritus in adult palliative care patients
Boehlke, C. S., Joos, L., Couné, B., Becker, C., Meerpohl, J. J., Buroh, S., Hercz, D., Schwarzer, G., & Becker, G. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008320.pub4 · Cited by 19
Mittal, A. K. (2016) · Current problems in dermatology · doi:10.1159/000446057 · Cited by 17
Review article: the management of primary sclerosing cholangitis
Mitchell, S. A., & Chapman, R. W. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.91263000.x · Cited by 17
Drug Treatments for Pruritus in Adult Palliative Care
Siemens, W., Xander, C. J., Meerpohl, J. J., Antes, G., & Becker, G. (2014) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2014.0863 · Cited by 16
Xu, C., Yue, R., Lv, X., Wang, S., & Du, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.835991 · Cited by 17
Systematic review: efficacy of therapies for cholestatic pruritus
Ebhohon, E., & Chung, R. T. (2023) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848231172829 · Cited by 16
Patil, A., & Mayo, M. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-118-5_9 · Cited by 16
Novel strategies and therapeutic options for the management of primary biliary cholangitis
Khanna, A., & Jones, D. E. (2017) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x17728669 · Cited by 16
Parés, A. R. (2018) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2018.07.009 · Cited by 15
Self-citationLisboa, L. F., Asthana, S., Kremer, A. E., Swain, M. G., Bagshaw, S. M., Gibney, R. T. N., & Karvellas, C. J. (2012) · Canadian Journal of Gastroenterology · doi:10.1155/2012/623862 · Cited by 15
Yosipovitch, G. (2003) · Current Problems in Dermatology · doi:10.1016/s1040-0486(03)00017-6 · Cited by 15
Carbone, M., Gerussi, A., Cardinale, V., Cazzagon, N., Cossiga, V., Lleò, A., Marrone, G., Marzioni, M., Moschetta, A., Muratori, L., et al. (2024) · Digestive and Liver Disease · doi:10.1016/j.dld.2024.05.002 · Cited by 18
Elfaki, D., Bjornsson, E. S., & Lindor, K. D. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04104.x · Cited by 14
Current and promising therapy for primary biliary cholangitis
Gossard, A. A., & Lindor, K. D. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1601701 · Cited by 15
Hepatobiliary pruritus: What are effective treatments?
Connolly, C., Kantor, G. R., & Menduke, H. (1995) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(95)91818-3 · Cited by 14
Howard, P. D., Twycross, R., Grove, G. L., Charlesworth, S. A., Mihalyo, M., & Wilcock, A. (2015) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2015.09.004 · Cited by 13
An approach to the management of the pruritus of cholestasis
Bergasa, N. V. (2004) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00128-4 · Cited by 13
Nuclear receptor ligands in therapy of cholestatic liver disease
Sturm, E. (2009) · Frontiers in bioscience · doi:10.2741/3529 · Cited by 12
Lazaridis, K. N., & Lindor, K. D. (1999) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-999-0051-0 · Cited by 12
Pregnane X receptor in drug-induced liver injury: Friend or foe?
Shehu, A. I., & Ma, X. (2018) · Liver Research · doi:10.1016/j.livres.2018.12.002 · Cited by 11
S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Langversion 4.0
Bitzer, M., Groß, S., Albert, J., Blödt, S., Boda‐Heggemann, J., Brunner, T. B., Caspari, R., Toni, E. D., Dombrowski, F., Evert, M., et al. (2024) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2189-6353 · Cited by 10
Ahmed, A., & Mayo, M. J. (2014) · Clinical gastroenterology · doi:10.1007/978-1-4939-1013-7_9 · Cited by 10
Efficacy of Treatments for Cholestatic Pruritus: A Systemic Review and Meta-analysis
Dervout, C., Boulais, N., Barnetche, T., Nousbaum, J., Brenaut, E., & Misery, L. (2022) · Acta Dermato Venereologica · doi:10.2340/actadv.v102.310 · Cited by 12
Medical and endoscopic treatment in primary sclerosing cholangitis
Meier, P. N., & Manns, M. P. (2001) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2001.0211 · Cited by 10
Itching for Answers: A Comprehensive Review of Cholestatic Pruritus Treatments
Gabrielli, F., Crepaldi, E., Cavicchioli, A., Rivi, M., Costanzo, A. A. C., Cursaro, C., & Andreoné, P. (2024) · Biomolecules · doi:10.3390/biom14101227 · Cited by 11
Terán, Á., Fábrega, E., & Pons‐Romero, F. (2009) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2009.07.006 · Cited by 9
S3-Leitlinie: Diagnostik und Therapie des hepatozellulären Karzinoms
Voesch, S., Bitzer, M., Jörg, A., Bartenstein, P., Bechstein, W. O., Blödt, S., Thomas, B., Dombrowski, F., Evert, M., Follmann, M., et al. (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1589-7568 · Cited by 9
Intractable Pruritus in Patients With Hepatitis C Virus
Novelli, G., Rossi, M., Poli, L., Predagostini, R., Iappelli, M., Morabito, V., Lai, Q., Novelli, L., Mennini, G., Corradini, S. G., et al. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.03.047 · Cited by 8
Review of management of pruritus in palliative care
Alshammary, S. A., Duraisamy, B. P., & Alsuhail, A. (2016) · Journal of Health Specialties · doi:10.4103/1658-600x.173844 · Cited by 8
Medical and nutritional management of cholestasis in infants and children
Feranchak, A. P., Suchy, F. J., & Sokol, R. J. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139012102.010 · Cited by 8
On rifampin treatment of psoriasis
Tsankov, N., & Krasteva, M. (1993) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(08)82050-6 · Cited by 8
Symptom burden in chronic liver disease
Hassan, A., de León, I. H.-D., & Tapper, E. B. (2023) · Gastroenterology report · doi:10.1093/gastro/goae078 · Cited by 7
Hepatic Diseases in the Elderly
Dam, J. V., & Zeldis, J. B. (1990) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00506-9 · Cited by 7
Autorinnen/Autoren, & Collaborators (2025) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2558-5204 · Cited by 6
Greaves, M. W. (2010) · Wiley eBooks · doi:10.1002/9781444317633.ch21 · Cited by 6
Pharmacological interventions for pruritus in adult palliative care patients
Xander, C. J., Meerpohl, J. J., Galandi, D., Buroh, S., Motschall, E., Schwarzer, G., Antes, G., & Becker, G. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008320 · Cited by 6
Rifampicin Induces Bicarbonate-Rich Choleresis in Rats: Involvement of Anion Exchanger 2
Wang, W., Ren, X., Cai, Y., Chen, L., Zhang, W., & Xu, J. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3850-2 · Cited by 5
Esmaeili, A., Toosi, M. N., Taher, M., Merat, S., Bayani, J., Karimian, Z., Esmaeili, A., Moazzami, B., & Namazi, S. (2021) · Europe PMC (PubMed Central) · doi:10.22037/ijpr.2020.112942.14024 · Cited by 5
Tack, M. (2021) · Journal of Health Psychology · doi:10.1177/13591053211059391 · Cited by 5
Primary Sclerosing Cholangitis
Enns, R. A. (2006) · Wiley eBooks · doi:10.1002/9780470986981.ch19 · Cited by 5
S3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion
Bitzer, M., Groß, S., Albert, J., Boda‐Heggemann, J., Brunner, T. B., Caspari, R., Toni, E. D., Dombrowski, F., Evert, M., Geier, A., et al. (2023) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2026-1240 · Cited by 4
Itch Management: Systemic Agents
Pongcharoen, P., & Fleischer, A. B. (2016) · Current problems in dermatology · doi:10.1159/000446041 · Cited by 4
Melatonin effect on platelet count in patients with liver disease.
Esmaeili, A., Toosi, M. N., Taher, M., Bayani, J., & Namazi, S. (2021) · Gastroenterology and hepatology from bed to bench. · Cited by 4
Jaundice, ascites, and encephalopathy
Keen, J. (2015) · doi:10.1093/med/9780199656097.003.0204 · Cited by 4
Therapie cholestatischer Lebererkrankungen
Gatzen, M., & Pausch, J. (2002) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-002-1139-7 · Cited by 3
Complications of Liver Disease
Bergasa, N. V. (2021) · Springer eBooks · doi:10.1007/978-1-4471-4715-2_15 · Cited by 4
Disorders of the liver, gallbladder and pancreas
Crossley, I. R. (1991) · Reviews in Clinical Gerontology · doi:10.1017/s0959259800002562 · Cited by 4
Pruritus, Prurigo and Lichen Simplex
Ständer, S., & Greaves, M. W. (2016) · Wiley eBooks · doi:10.1002/9781118441213.rtd0084 · Cited by 4
S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0
Groß, S., Bitzer, M., Albert, J., Blödt, S., Boda‐Heggemann, J., Brunner, T. B., Caspari, R., Toni, E. D., Dombrowski, F., Evert, M., et al. (2024) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2189-8567 · Cited by 3
Gastroenterology and Hepatology
Carey, W. D. (1991) · JAMA · doi:10.1001/jama.1991.03460230071015 · Cited by 3
Bergasa, N. V., & Jones, E. A. (1998) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70014-3 · Cited by 3
Treatment of primary biliary cirrhosis.
Parés, A. R., & Rodés, J. (2000) · PubMed · Cited by 3
Self-citationRolling review: autoimmune liver disease
Mitchison, H. C., & Bassendine, M. F. (1993) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1993.tb00075.x · Cited by 3
Primary Biliary Cirrhosis and Sclerosing Cholangitis
Parés, A., & Rodés, J. (1992) · Springer eBooks · doi:10.1007/978-3-642-76802-6_22 · Cited by 6
Self-citationS3-Leitlinie Diagnostik und Therapie biliärer Karzinome – Langversion
Groß, S., Bitzer, M., Albert, J., Blödt, S., Boda‐Heggemann, J., Borucki, K., Brunner, T. B., Caspari, R., Dombrowski, F., Evert, M., et al. (2025) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2460-6347 · Cited by 3
S3-Leitlinie Diagnostik und Therapie des Hepatozellulären Karzinoms – Langversion
Bitzer, M., Groß, S., Albert, J., Blödt, S., Boda‐Heggemann, J., Borucki, K., Brunner, T. B., Caspari, R., Dombrowski, F., Evert, M., et al. (2025) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2460-6298 · Cited by 4
Sebode, M., Bantel, H., Baumann, U., Bufler, P., Demir, M., Dold, L., Keitel, V., Klein, R., Kremer, A. E., Jansen, P. L., et al. (2026) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2769-2475 · Cited by 2
Pruritus, Fatigue, Osteoporosis and Dyslipoproteinemia in Pbc Patients: A Clinician’s Perspective
Dražilová, S., Koky, T., Macej, M., Janíčko, M., Simkova, D., Tsedendamba, A., Комарова, С. Г., & Jarčuška, P. (2024) · Gastroenterology Insights · doi:10.3390/gastroent15020030 · Cited by 2
Dermatologic Conditions and Symptom Control
Bower, K. A., Mulder, G., Reineke, A., & Guide, S. V. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0262-0.00035-9 · Cited by 2
Treatment Effect of Rifampicin on Cholestasis
(2005) · The Internet Journal of Pharmacology · doi:10.5580/1bf3 · Cited by 2
Mayo, M. J., & Thiele, D. L. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch100 · Cited by 2
Pathophysiologic Basis for Alternative Therapies for Cholestasis
Fuchs, C. D., Halilbasic, E., & Trauner, M. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch30 · Cited by 2
Cuperus, F. J. C., Claudel, T., Gautherot, J., Halilbasic, E., & Trauner, M. A. (2014) · Cited by 1
Treatments in Chronic Cholestasis in Children
Álvarez, F. (2008) · Annales Nestlé (English ed ) · doi:10.1159/000147410 · Cited by 1
Metadata
- Authors
- Bachs, L., Elena, M., Parés, A., Piera, C., & Rodés, J.
- Affiliations
- Hospital Clínic de Barcelona (ES)
- Universitat de Barcelona (ES)
- ORCID
- Parés, Albert
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1989-03
- Volume
- 333
- Issue
- 8638
- Pages
- 574-576
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2088682754
- Cited by
- 231
- References
- 23
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 8 · 2023: 8 · 2022: 6 · 2021: 4 · 2020: 4 · 2019: 6 · 2018: 9 · 2017: 6 · 2016: 8 · 2015: 9 · 2014: 10 · 2013: 4 · 2012: 3
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- rifampicin, phenobarbital, pruritus, primary biliary cirrhosis, antipruritic effect, cholestasis, drug-induced liver injury, anemia, renal failure
- MeSH terms
- Adult, Cholestasis, Clinical Trials as Topic, Drug Administration Schedule, Female, Humans, Liver Cirrhosis, Biliary, Microsomes, Liver, Middle Aged, Phenobarbital, Pruritus, Random Allocation, Rifampin, Severity of Illness Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review